Characteristic | 30-day all-cause mortality group | Survival group | P-value† | |
---|---|---|---|---|
Acute kidney injury (+) | Number of patients | 5 | 6 | – |
Vancomycin trough concentration (μg/mL)a | 26 (22.3–33.2) | 12.8 (9.1–30.5) | 0.20 i) | |
Vancomycin AUC24 (μg/mL·h)a | 859 (393–971) | 794 (486–1052) | 0.86 i) | |
Vancomycin AUC24/MIC ratioa | 859 (427–971) | 809 (459–1409) | 0.86 i) | |
Number of cases with failure to achieve a vancomycin AUC24/MIC ratio ≤ 389 | 1 | 0 | 0.45 ii) | |
Acute kidney injury (−) | Number of patients | 7 | 27 | – |
Vancomycin trough concentration (μg/mL)a | 15.0 (12.7–21.4) | 14.6 (9.3–18.2) | 0.30 i) | |
Vancomycin AUC24 (μg/mL·h)a | 498 (354–765) | 645 (417–853) | 0.48 i) | |
Vancomycin AUC24/MIC ratioa | 725 (277–1531) | 707 (417–1319) | 0.75 i) | |
Number of cases with failure to achieve a vancomycin AUC24/MIC ratio ≤ 389 | 2 | 5 | 0.61 ii) |